Your browser doesn't support javascript.
loading
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study.
Whitaker, Heather J; Tsang, Ruby S M; Byford, Rachel; Aspden, Carole; Button, Elizabeth; Sebastian Pillai, Praveen; Jamie, Gavin; Kar, Debasish; Williams, John; Sinnathamby, Mary; Marsden, Gemma; Elson, William H; Leston, Meredith; Anand, Sneha; Okusi, Cecilia; Fan, Xuejuan; Linley, Ezra; Rowe, Cathy; DArcangelo, Silvia; Otter, Ashley D; Ellis, Joanna; Hobbs, F D Richard; Tzortziou-Brown, Victoria; Zambon, Maria; Ramsay, Mary; Brown, Kevin E; Amirthalingam, Gayatri; Andrews, Nick J; de Lusignan, Simon; Lopez Bernal, Jamie.
Afiliação
  • Whitaker HJ; Statistics, Modelling and Economics Department, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Tsang RSM; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Byford R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Aspden C; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Button E; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Sebastian Pillai P; Virus Reference Laboratory, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Jamie G; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Kar D; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Williams J; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Sinnathamby M; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Marsden G; Royal College of General Practitioners Research and Surveillance Centre, Euston Square, London NW1 2FB, UK.
  • Elson WH; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Leston M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Anand S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Okusi C; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Fan X; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Linley E; Vaccine Evaluation Unit, UK Health Security Agency, Manchester M13 9WL, UK.
  • Rowe C; Diagnostics and Genomics, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • DArcangelo S; Diagnostics and Genomics, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • Otter AD; Diagnostics and Genomics, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • Ellis J; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK; Virus Reference Laboratory, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
  • Tzortziou-Brown V; Royal College of General Practitioners Research and Surveillance Centre, Euston Square, London NW1 2FB, UK.
  • Zambon M; Virus Reference Laboratory, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Ramsay M; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Brown KE; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Amirthalingam G; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Andrews NJ; Statistics, Modelling and Economics Department, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK; Royal College of General Practitioners Research and Surveillance Centre, Euston Square, London NW1 2FB, UK.
  • Lopez Bernal J; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK. Electronic address: jamie.lopezbernal2@ukhsa.gov.uk.
J Infect ; 87(4): 315-327, 2023 10.
Article em En | MEDLINE | ID: mdl-37579793
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido